Locally Advanced Breast Cancer (LABC)

Also known as: Locally Advance Breast Cancer (LABC) / Locally Advanced Breast Cancer / Locally advanced breast cancer (disorder) / Malignant neoplasm of breast of unspecified site / Malignant neoplasm of breast / Malignant breast neoplasm / Breast cancer / Malignant neoplasm of breast (disorder) / Breast tumor malignant / Breast tumour malignant / Breast cancer NOS / Breast cancer stage unspecified

DrugDrug NameDrug Description
DB01217AnastrozoleA competitive, selective, non-steroidal aromatase inhibitor used as adjuvant therapy for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
DB01248DocetaxelA taxoid antineoplastic agent used in the treatment of various cancers, such as locally advanced or metastatic breast cancer, metastatic prostate cancer, gastric adenocarcinoma, and head and neck cancer.
DB06374ElacestrantAn estrogen receptor antagonist used to treat ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer with disease progression following at least one line of endocrine therapy.
DB06205Hyaluronidase (human recombinant)An enzyme used to improve the absorption and dispersion of parenterally administered fluids, drugs, and contrast agents.
DB04845IxabepiloneA microtubule inhibitor administered in combination with capecitabine or alone in the treatment of metastatic or locally advanced breast cancer that has shown inadequate response to taxanes and anthracyclines.
DB09074OlaparibA poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer.
DB06366PertuzumabAn antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents.
DB11760TalazoparibA poly-ADP ribose polymerase inhibitor used to treat HER2-, BRCA mutated locally advanced or metastatic breast cancer and HRR gene-mutated metastatic castration-resistant prostate cancer.
DB00072TrastuzumabA monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers.
DrugDrug NameTargetType
DB01217AnastrozoleCytochrome P450 19A1target
DB01217AnastrozoleP-glycoprotein 1transporter
DB01217AnastrozoleCytochrome P450 3A4enzyme
DB01217AnastrozoleCytochrome P450 3A5enzyme
DB01217AnastrozoleCytochrome P450 2C8enzyme
DB01217AnastrozoleUDP-glucuronosyltransferase 1-4enzyme
DB01217AnastrozoleUDP-glucuronosyltransferase 1-3enzyme
DB01217AnastrozoleUDP-glucuronosyltransferase 2B7enzyme
DB01217AnastrozoleCytochrome P450 1A2enzyme
DB01217AnastrozoleCytochrome P450 2C9enzyme
DB01248DocetaxelApoptosis regulator Bcl-2target
DB01248DocetaxelTubulin beta-1 chaintarget
DB01248DocetaxelCytochrome P450 3A4enzyme
DB01248DocetaxelCytochrome P450 3A5enzyme
DB01248DocetaxelCytochrome P450 3A7enzyme
DB01248DocetaxelP-glycoprotein 1transporter
DB01248DocetaxelMultidrug resistance-associated protein 7transporter
DB01248DocetaxelCytochrome P450 1B1enzyme
DB01248DocetaxelMicrotubule-associated protein 2target
DB01248DocetaxelMicrotubule-associated protein 4target
DB01248DocetaxelMicrotubule-associated protein tautarget
DB01248DocetaxelSolute carrier organic anion transporter family member 1B3transporter
DB01248DocetaxelSolute carrier family 22 member 7transporter
DB01248DocetaxelATP-binding cassette sub-family G member 2transporter
DB01248DocetaxelCanalicular multispecific organic anion transporter 1transporter
DB01248DocetaxelMultidrug resistance-associated protein 1transporter
DB01248DocetaxelNuclear receptor subfamily 1 group I member 2target
DB06374ElacestrantEstrogen receptor alphatarget
DB06374ElacestrantCytochrome P450 3A4enzyme
DB06374ElacestrantCytochrome P450 2A6enzyme
DB06374ElacestrantCytochrome P450 2C9enzyme
DB06374ElacestrantSolute carrier organic anion transporter family member 2B1transporter
DB06374ElacestrantP-glycoprotein 1transporter
DB06374ElacestrantATP-binding cassette sub-family G member 2transporter
DB06205Hyaluronidase (human recombinant)Hyaluronic acidtarget
DB06205Hyaluronidase (human recombinant)Transforming growth factor beta-1target
DB04845IxabepiloneTubulin beta-3 chaintarget
DB04845IxabepiloneCytochrome P450 3A4enzyme
DB04845IxabepiloneP-glycoprotein 1transporter
DB09074OlaparibPoly [ADP-ribose] polymerase 1target
DB09074OlaparibCytochrome P450 3A4enzyme
DB09074OlaparibCytochrome P450 2B6enzyme
DB09074OlaparibPoly [ADP-ribose] polymerase 2target
DB09074OlaparibPoly [ADP-ribose] polymerase 3target
DB09074OlaparibCytochrome P450 3A5enzyme
DB09074OlaparibP-glycoprotein 1transporter
DB09074OlaparibATP-binding cassette sub-family G member 2transporter
DB09074OlaparibAldo-keto reductase family 1 member C3target
DB09074OlaparibUDP-glucuronosyltransferase 1-1enzyme
DB09074OlaparibSerum albumincarrier
DB09074OlaparibAlpha-1-acid glycoprotein 1carrier
DB06366PertuzumabReceptor tyrosine-protein kinase erbB-2target
DB11760TalazoparibPoly [ADP-ribose] polymerase 1target
DB11760TalazoparibPoly [ADP-ribose] polymerase 2target
DB11760TalazoparibP-glycoprotein 1transporter
DB11760TalazoparibATP-binding cassette sub-family G member 2transporter
DB00072TrastuzumabReceptor tyrosine-protein kinase erbB-2target
DrugDrug NamePhaseStatusCount
DB12001Abemaciclib0Withdrawn1
DB11714Durvalumab0Withdrawn1
DB01362Iohexol0Recruiting1
DB09274Artesunate1Completed1
DB11945Avelumab1Recruiting1
DB01101Capecitabine1Completed1
DB12483Copanlisib1Terminated1
DB11651Dactolisib1Completed1
DB00947Fulvestrant1Active Not Recruiting1
DB01259Lapatinib1Completed1
DB09074Olaparib1Active Not Recruiting1
DB09073Palbociclib1Active Not Recruiting1
DB09073Palbociclib1Recruiting1
DB09037Pembrolizumab1Recruiting1
DB00072Trastuzumab1Completed1
DB05773Trastuzumab emtansine1Terminated1
DB16412Adebrelimab1 / 2Recruiting1
DB14776Camrelizumab1 / 2Recruiting1
DB00958Carboplatin1 / 2Recruiting1
DB00531Cyclophosphamide1 / 2Recruiting1
DB17456Dalpiciclib1 / 2Recruiting1
DB06374Elacestrant1 / 2Recruiting1
DB00445Epirubicin1 / 2Recruiting1
DB15637Fluzoparib1 / 2Recruiting1
DB00014Goserelin1 / 2Recruiting1
DB01006Letrozole1 / 2Recruiting1
DB15110Onvansertib1 / 2Recruiting1
DB01229Paclitaxel1 / 2Recruiting2
DB09073Palbociclib1 / 2Recruiting1
DB06366Pertuzumab1 / 2Recruiting1
DB14993Pyrotinib1 / 2Recruiting1
DB16061Samuraciclib1 / 2Recruiting1
DB00072Trastuzumab1 / 2Recruiting1
DB12001Abemaciclib2Active Not Recruiting1
DB12001Abemaciclib2Recruiting1
DB18290Anvatabart opadotin2Recruiting1
DB00112Bevacizumab2Completed1
DB00958Carboplatin2Recruiting1
DB00958Carboplatin2Terminated1
DB14707Cemiplimab2Recruiting1
DB00531Cyclophosphamide2Active Not Recruiting1
DB00531Cyclophosphamide2Terminated1
DB16410Datopotamab deruxtecan2Recruiting1
DB01248Docetaxel2Terminated1
DB15627Dostarlimab2Recruiting1
DB00997Doxorubicin2Recruiting1
DB00997Doxorubicin2Terminated1
DB11714Durvalumab2Recruiting1
DB00947Fulvestrant2Active Not Recruiting1
DB00947Fulvestrant2Recruiting1
DB12047Ganetespib2Recruiting1
DB12205Ganitumab2Recruiting1
DB00441Gemcitabine2Completed1
DB00014Goserelin2Recruiting1
DB01275Hydralazine2Terminated1
DB17457Inetetamab2Recruiting1
DB00762Irinotecan2Recruiting1
DB12437Irosustat2Completed1
DB15409Ladiratuzumab vedotin2Recruiting1
DB06202Lasofoxifene2Recruiting1
DB01006Letrozole2Recruiting2
DB14123Menthol2Recruiting1
DB00331Metformin2Recruiting1
DB11828Neratinib2Recruiting1
DB09074Olaparib2Recruiting1
DB01229Paclitaxel2Recruiting2
DB01229Paclitaxel2Terminated1
DB01229Paclitaxel2Withdrawn1
DB09073Palbociclib2Recruiting1
DB12090Patritumab2Recruiting1
DB00019Pegfilgrastim2Terminated1
DB09037Pembrolizumab2Recruiting1
DB09037Pembrolizumab2Withdrawn1
DB06366Pertuzumab2Recruiting2
DB06366Pertuzumab2Terminated1
DB12978Pexidartinib2Recruiting1
DB11730Ribociclib2Recruiting1
DB16061Samuraciclib2Recruiting1
DB11760Talazoparib2Recruiting1
DB15295Tenalisib2Completed1
DB00072Trastuzumab2Recruiting1
DB00072Trastuzumab2Terminated1
DB14962Trastuzumab deruxtecan2Recruiting1
DB16342Trastuzumab duocarmazine2Recruiting1
DB05773Trastuzumab emtansine2Recruiting1
DB12056Trebananib2Recruiting1
DB15442Trilaciclib2Recruiting1
DB11652Tucatinib2Recruiting1
DB00313Valproic acid2Terminated1
DB07232Veliparib2Recruiting1
DB15471Zanidatamab2Recruiting1
DB00399Zoledronic acid2Completed1
DB00990Exemestane3Completed1
DB00947Fulvestrant3Completed1
DB06205Hyaluronidase (human recombinant)3Active Not Recruiting1
DB06366Pertuzumab3Active Not Recruiting1
DB14993Pyrotinib3Recruiting1
DB00072Trastuzumab3Active Not Recruiting1
DB05773Trastuzumab emtansine3Active Not Recruiting1
DB01248Docetaxel4Completed1
DB01006Letrozole4Completed1
DB01006Letrozole4Recruiting1